X-120077100-A-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001099685.3(RHOXF2B):c.268T>A(p.Trp90Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in Lovd as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.000023 ( 0 hom., 1 hem., cov: 14)
Exomes 𝑓: 0.000020 ( 1 hom. 8 hem. )
Failed GnomAD Quality Control
Consequence
RHOXF2B
NM_001099685.3 missense
NM_001099685.3 missense
Scores
17
Clinical Significance
Conservation
PhyloP100: -0.761
Genes affected
RHOXF2B (HGNC:33519): (Rhox homeobox family member 2B) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in positive regulation of gene expression. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06464949).
BP6
Variant X-120077100-A-T is Benign according to our data. Variant chrX-120077100-A-T is described in Lovd as [Likely_benign].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOXF2B | NM_001099685.3 | c.268T>A | p.Trp90Arg | missense_variant | 2/4 | ENST00000371402.5 | NP_001093155.1 | |
RHOXF1-AS1 | NR_131238.1 | n.297+40568A>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOXF2B | ENST00000371402.5 | c.268T>A | p.Trp90Arg | missense_variant | 2/4 | 1 | NM_001099685.3 | ENSP00000360455.3 | ||
RHOXF1-AS1 | ENST00000553843.5 | n.297+40568A>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000228 AC: 2AN: 87652Hom.: 0 Cov.: 14 AF XY: 0.0000474 AC XY: 1AN XY: 21110
GnomAD3 genomes
AF:
AC:
2
AN:
87652
Hom.:
Cov.:
14
AF XY:
AC XY:
1
AN XY:
21110
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000327 AC: 5AN: 153003Hom.: 0 AF XY: 0.0000819 AC XY: 4AN XY: 48839
GnomAD3 exomes
AF:
AC:
5
AN:
153003
Hom.:
AF XY:
AC XY:
4
AN XY:
48839
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000197 AC: 19AN: 963783Hom.: 1 Cov.: 30 AF XY: 0.0000291 AC XY: 8AN XY: 274873
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
19
AN:
963783
Hom.:
Cov.:
30
AF XY:
AC XY:
8
AN XY:
274873
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000228 AC: 2AN: 87652Hom.: 0 Cov.: 14 AF XY: 0.0000474 AC XY: 1AN XY: 21110
GnomAD4 genome
AF:
AC:
2
AN:
87652
Hom.:
Cov.:
14
AF XY:
AC XY:
1
AN XY:
21110
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2024 | The c.268T>A (p.W90R) alteration is located in exon 2 (coding exon 2) of the RHOXF2B gene. This alteration results from a T to A substitution at nucleotide position 268, causing the tryptophan (W) at amino acid position 90 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of methylation at W90 (P = 0.0422);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at